These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 16181349

  • 1. Immunity markers in patients with Helicobacter pylori infection: effect of eradication.
    Dore MP, Fastame L, Tocco A, Negrini R, Delitala G, Realdi G.
    Helicobacter; 2005 Oct; 10(5):391-7. PubMed ID: 16181349
    [Abstract] [Full Text] [Related]

  • 2. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases.
    Chomvarin C, Ottiwet O, Hahnvajanawong C, Intapan PM, Wongwajana S.
    Int J Infect Dis; 2009 Sep; 13(5):647-54. PubMed ID: 19233700
    [Abstract] [Full Text] [Related]

  • 3. Long-term re-infection rate after Helicobacter pylori eradication in Bangladeshi adults.
    Ahmad MM, Ahmed DS, Rowshon AH, Dhar SC, Rahman M, Hasan M, Beglinger C, Gyr N, Khan AK.
    Digestion; 2007 Sep; 75(4):173-6. PubMed ID: 17700024
    [Abstract] [Full Text] [Related]

  • 4. Impaired host immunity contributes to Helicobacter pylori eradication failure.
    Borody T, Ren Z, Pang G, Clancy R.
    Am J Gastroenterol; 2002 Dec; 97(12):3032-7. PubMed ID: 12492186
    [Abstract] [Full Text] [Related]

  • 5. Eradication therapy in Helicobacter pylori-positive patients with halitosis: long-term outcome.
    Katsinelos P, Tziomalos K, Chatzimavroudis G, Vasiliadis T, Katsinelos T, Pilpilidis I, Triantafillidis I, Paroutoglou G, Papaziogas B.
    Med Princ Pract; 2007 Dec; 16(2):119-23. PubMed ID: 17303947
    [Abstract] [Full Text] [Related]

  • 6. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
    Klaamas K, Kurtenkov O, von Mensdorff-Pouilly S, Shljapnikova L, Miljukhina L, Brjalin V, Lipping A.
    Immunol Invest; 2007 Dec; 36(4):371-86. PubMed ID: 17691020
    [Abstract] [Full Text] [Related]

  • 7. Platelet response to Helicobacter pylori eradication therapy in adult chronic idiopathic thrombocytopenic purpura seems to be related to the presence of anticytotoxin-associated gene A antibodies.
    Scandellari R, Allemand E, Vettore S, Plebani M, Randi ML, Fabris F.
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):108-13. PubMed ID: 19786938
    [Abstract] [Full Text] [Related]

  • 8. Cytotoxin associated gene A-positive Helicobacter pylori strains in dyspeptic pregnant women.
    Noyan V, Apan TZ, Yucel A, Sagsoz N.
    Eur J Obstet Gynecol Reprod Biol; 2004 Oct 15; 116(2):186-9. PubMed ID: 15358462
    [Abstract] [Full Text] [Related]

  • 9. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI, Makarenko EV, Voropaeva AV, Matveenko ME, Voropaev EV.
    J Gastroenterol Hepatol; 2008 Nov 15; 23(11):1666-71. PubMed ID: 17559360
    [Abstract] [Full Text] [Related]

  • 10. Eradication of Helicobacter pylori infection equally improves chronic urticaria with positive and negative autologous serum skin test.
    Magen E, Mishal J, Schlesinger M, Scharf S.
    Helicobacter; 2007 Oct 15; 12(5):567-71. PubMed ID: 17760727
    [Abstract] [Full Text] [Related]

  • 11. Effect of Helicobacter pylori infection and eradication therapy on interleukin-6 levels in patients with Familial Mediterranean Fever.
    Ozel AM, Demirturk L, Aydogdu A, Gultepe M, Yazgan Y, Imirzalioglu N, Gurbuz AK, Narin Y.
    Int J Clin Pract; 2008 May 15; 62(5):754-61. PubMed ID: 17343670
    [Abstract] [Full Text] [Related]

  • 12. Organ-specific autoantibodies in children with Helicobacter pylori infection.
    Guariso G, Brotto F, Basso D, Alaggio R, Betterle C.
    Helicobacter; 2004 Dec 15; 9(6):622-8. PubMed ID: 15610075
    [Abstract] [Full Text] [Related]

  • 13. Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates.
    Romano M, Iovene MR, Russo MI, Rocco A, Salerno R, Cozzolino D, Pilloni AP, Tufano MA, Vaira D, Nardone G.
    J Clin Pathol; 2008 Oct 15; 61(10):1112-5. PubMed ID: 18755715
    [Abstract] [Full Text] [Related]

  • 14. Normal serum pepsinogen I levels in adults: a population-based study with special reference to Helicobacter pylori infection and parietal cell antibodies.
    Hokkanen S, Kosunen TU, Sarna S, Miettinen A, Salomaa A, Aromaa A, Knekt P, Rautelin HI.
    Scand J Clin Lab Invest; 2005 Oct 15; 65(4):291-9. PubMed ID: 16076684
    [Abstract] [Full Text] [Related]

  • 15. Role of Helicobacter pylori virulence factor and genotypes in non-ulcer dyspepsia.
    Tan HJ, Rizal AM, Rosmadi MY, Goh KL.
    J Gastroenterol Hepatol; 2006 Jan 15; 21(1 Pt 1):110-5. PubMed ID: 16706821
    [Abstract] [Full Text] [Related]

  • 16. Immune response to CagA protein is associated with improved platelet count after Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura.
    Kodama M, Kitadai Y, Ito M, Kai H, Masuda H, Tanaka S, Yoshihara M, Fujimura K, Chayama K.
    Helicobacter; 2007 Feb 15; 12(1):36-42. PubMed ID: 17241299
    [Abstract] [Full Text] [Related]

  • 17. [Genetic type of Helicobacter pylori and the efficacy of eradication therapy].
    Parzecka M, Szaflarska-Popławska A, Mierzwa G, Gorzkiewicz M, Łuczak S, Grzybowski T.
    Pol Merkur Lekarski; 2009 Feb 15; 26(152):105-9. PubMed ID: 19388513
    [Abstract] [Full Text] [Related]

  • 18. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ, Lee DH, Kim N, Jung SH, Kim JW, Hwang JH, Park YS, Lee KH, Jung HC, Song IS.
    Hepatogastroenterology; 2007 Jun 15; 54(76):1293-6. PubMed ID: 17629092
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.
    Cindoruk M, Erkan G, Karakan T, Dursun A, Unal S.
    Helicobacter; 2007 Aug 15; 12(4):309-16. PubMed ID: 17669103
    [Abstract] [Full Text] [Related]

  • 20. One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection.
    Hsu CC, Chen JJ, Hu TH, Lu SN, Changchien CS.
    Hepatogastroenterology; 2005 Aug 15; 52(65):1617-21. PubMed ID: 16201128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.